{"url_path":"/sec/onco/8-k/2026-05-14/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1782107/0001213900-26-056109-index.html","accession_number":"0001213900-26-056109","cik":"0001782107","ticker":"ONCO","issuer_name":"Onconetix, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1782107/0001213900-26-056109-index.html","primary_entity_key":"0001782107","primary_entity_name":"Onconetix, Inc."},"word_count":98,"has_tables":true,"body_markdown":"** **\n\n**Item 9.01 Financial Statements and Exhibits.**\n\n \n\n(d) Exhibits\n\n \n\nThe following exhibits are being filed or furnished,\nas applicable, with this Current Report on Form 8-K:\n\n \n\n**Exhibit No.**\n \n**Description**\n\n99.1\n \n[Press Release, dated May 13, 2026.](ea029073901ex99-1.htm)\n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n \n\n1\n\n \n\n \n\n**SIGNATURES**\n\n** **\n\nPursuant to the requirements of the Securities\nExchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n**Onconetix, Inc.**\n\n \n \n\nMay 13, 2026\nBy:\n*/s/ David Allan White*\n\n \nName:\nDavid Allan White\n\n \nTitle:\nChief Executive Officer\n\n \n\n2"}